Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
Journal of Neuroscience Research|March 10, 2017
Time-dependent change of in vivo optical imaging of oxidative stress in a mouse stroke modelYumiko Nakano, Toru Yamashita, Qian Li, et al.Case Reports in Neurology|March 12, 2021
Two Cases of Probable Neuro-Behçet's Disease with Longitudinally Extensive Transverse MyelitisShunya Fujiwara, Yasuhiro Manabe, Yumiko Nakano, et al.Scientific Reports|September 3, 2024
Suppression of PTBP1 in hippocampal astrocytes promotes neurogenesis and ameliorates recognition memory in mice with cerebral ischemiaYusuke Fukui, Ryuta Morihara, Xinran Hu, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS)Yumiko Nakano, Kosuke Matsuzono, Toru Yamashita, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS)Kosuke Matsuzono, Toru Yamashita, Yasuyuki Ohta, et al.Journal of Alzheimer'S Disease : JAD|April 16, 2016
Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in Alzheimer's Disease Mouse ModelYun Zhai, Toru Yamashita, Yumiko Nakano, et al.Neuromuscular Disorders : NMD|January 18, 2023
A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysisRyo Sasaki, Taijun Yunoki, Yumiko Nakano, et al.Scientific Reports|July 31, 2019
In vivo direct reprogramming of glial linage to mature neurons after cerebral ischemiaToru Yamashita, Jingwei Shang, Yumiko Nakano, et al.Geriatrics & Gerontology International|March 10, 2017
Different clinical effect of four antidementia drugs for Alzheimer's disease patients depending on white matter severityYusuke Fukui, Nozomi Hishikawa, Jin Ichinose, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS)Kosuke Matsuzono, Kota Sato, Syoichiro Kono, et al.Pageof 8